China NMPA Product Recall - Ventilator

The National Medical Products Administration (NMPA) announced a Level I medical device recall on January 27, 2015, involving Philips (China) Investment Co., Ltd. This recall primarily concerns 35 Respironics V50 and V60 ventilators, manufactured by Respironics California, Inc., that remained unlocated for a critical software upgrade. These affected units were shipped prior to April 1, 2013. The main issue requiring action is a mandatory PIC software upgrade for the power management board assembly in these ventilators to ensure proper functionality. By December 2014, Philips had successfully performed corrective actions on 1165 devices. However, 37 units remained unaddressed; two were due to distributors refusing access, necessitating warning labels, and the remaining 35 could not be located, leading Philips to publicly list their details. Philips initiated the recall by notifying distributors on July 10, 2013, adhering to the NMPA's "Regulations on the Management of Medical Device Recalls (Trial Implementation)." The company encountered difficulties in obtaining installation information from distributors for many devices. Philips continues to provide the necessary software, accessories, and instructions, affirming its commitment to perform upgrades on any unlocated units once they are identified. No related adverse event reports have been received by Philips.